Lobbying Activity Report

2179-27743

Organization: MS Canada
Was this lobbying activity a letter sent on behalf of one or more of the organizations listed as members of a coalition in your Registration Return? No
Associated registration: 7955-2179-38
Lobbying Activity date: 2023-06-09
Arranged a meeting: No
Posted date: 2023-07-15

In-house lobbyists who participated in the lobbying activity: Alanah Duffy
Senior Public Office Holders who were lobbied in this activity: John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocating for timely access to approved multiple sclerosis(MS) therapies for people living with MS
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 COVID-19, Cannabis, Finances and Budgets, Health, Non-Profit Organization, Poverty
 
Senior officer who filed this Lobbying Activity Report: Pamela Valentine
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: